Large-cap Health Care company Johnson & Johnson has logged a -0.3% change today on a trading volume of 3,128,768. The average volume for the stock is 8,426,752.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. Based in New Brunswick, United States the company has 138,100 full time employees and a market cap of $425,096,085,504. Johnson & Johnson currently offers its equity investors a dividend that yields 2.8% per year.
The company is now trading -0.05% away from its average analyst target price of $176.6 per share. The 23 analysts following the stock have set target prices ranging from $155.0 to $200.0, and on average give Johnson & Johnson a rating of buy.
Over the last 52 weeks, JNJ stock has risen 9.5%, which amounts to a -5.0% difference compared to the S&P 500. The stock's 52 week high is $181.16 whereas its 52 week low is $140.68 per share. With its net margins declining an average -3.0% over the last 6 years, Johnson & Johnson may not have a strong enough profitability trend to support its stock price.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 88,821,000 | 14,066,000 | 16 | -27.27 |
| 2023 | 79,990,000 | 17,941,000 | 22 | -18.52 |
| 2022 | 78,740,000 | 20,878,000 | 27 | 50.0 |
| 2021 | 82,584,000 | 14,714,000 | 18 | 0.0 |
| 2019 | 82,059,000 | 15,119,000 | 18 | -5.26 |
| 2018 | 81,581,000 | 15,297,000 | 19 |
